SLC39A4 as a Novel Prognosis Marker Promotes Tumor Progression in Esophageal Squamous Cell Carcinoma
Chenmei Xia,1 Xia Chen,1 Jun Li,2 Peng Chen3 1Department of Gastroenterology, The First People’s Hospital of Wenling, Wenling 317500, People’s Republic of China; 2Department of Joint Surgery, The First People’s Hospital of Wenling, Wenling 317500, People’s Rep...
Main Authors: | Xia C, Chen X, Li J, Chen P |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-05-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/slc39a4-as-a-novel-prognosis-marker-promotes-tumor-progression-in-esop-peer-reviewed-article-OTT |
Similar Items
-
Transgelin Inhibits the Malignant Progression of Esophageal Squamous Cell Carcinomas by Regulating Epithelial–Mesenchymal Transition
by: Boli Yang, et al.
Published: (2021-08-01) -
Contribution of dysregulated circRNA_100876 to proliferation and metastasis of esophageal squamous cell carcinoma
by: Cao S, et al.
Published: (2018-10-01) -
CD73 Promotes Tumor Progression in Patients with Esophageal Squamous Cell Carcinoma
by: Yen-Hao Chen, et al.
Published: (2021-08-01) -
Downregulation of long non‐coding RNA LOC101928477 correlates with tumor progression by regulating the epithelial‐mesenchymal transition in esophageal squamous cell carcinoma
by: Demiao Kong, et al.
Published: (2021-05-01) -
Increased expression of SLC46A3 to oppose the progression of hepatocellular carcinoma and its effect on sorafenib therapy
by: Qing Zhao, et al.
Published: (2019-06-01)